Article | Publish date | Type or article | COVID-19 (M/F) | COVID-positive patient with smell disorder | Percentage | Smell identification | Notes | ||||
---|---|---|---|---|---|---|---|---|---|---|---|
Smell disorder | Anosmia | Hyposmia | Dysosmia | ||||||||
1 | Giacomelli et al [9] | Mar 2020 | Cross-sectional study | 59(40/19) | 17 | Unknown | 28.8% | Questionnaire | |||
2 | Vaira et al [10] | Apr 2020 | Rapid communication paper | 320 | 62 | Unknown | 19.4% | Questionnaire | |||
3 | Villalba et al [11] | Apr 2020 | Case series | 2(1/1) | 2 | Unknown | 100% | Questionnaire | |||
4 | Hjelmesæth et al [12] | Apr 2020 | Case series | 3 (2/1) | 3 | Unknown | 100% | Questionnaire | |||
5 | Lechien et al [13] | Apr 2020 | Cross-sectional multicenter study | 417 (154/263) | 357 | 284 | 73 | 85.6% | Questionnaire | ||
6 | Mao et al [14] | Apr 2020 | Retrospective study | 214 (87/127) | 11 | Unknown | 5.1% | Questionnaire | |||
7 | Gilani et al [15] | Apr 2020 | Case series | 5 (2/3) | 5 | Unknown | 100% | Questionnaire | |||
8 | Eliezer et al [16] | Apr 2020 | Case report | 1 (0/1) | 1 | Unknown | 100% | CCCRC | CT scan of the nasal cavity showed bilateral inflammatory obstruction of the olfactory clefts that was confirmed on MRI of the nasal cavity. There were no anomalies of the olfactory bulbs and tracts. | ||
9 | Yan et al [17] | Apr 2020 | Cross-sectional study | 59 (29/29/1) | 40 | Unknown | 67.8% | Questionnaire | Comparison between probability of acute smell loss in COVID-19 and normal individual | ||
10 | Klopfenstein et al [18] | Apr 2020 | Retrospective study | 144 | 54 | Unknown | 37.5% | Questionnaire | |||
11 | Moein et al [19] | Apr 2020 | Case-control study | 60 (20/40) | 59 | 15 | 44 | 98.3% | UPSITa | Smell disorder identification by history 21 patients / by test 59 patients | |
12 | Spinato et al [20] | Apr 2020 | Cross-sectional study | 202 (97/105) | 130 | 48 | 82 | 64.4% | Questionnaire | ||
13 | Beltrán-Corbellini et al [21] | Apr 2020 | Case-control study | 79 | 25 | 14 | 9 | 2 | 31.6% | Questionnaire | Comparison between probability of acute smell loss in COVID-19 and influenza patient |
14 | Yan et al [22] | Apr 2020 | Retrospective study | 128 (61/67) | 75 | Unknown | 58.6% | Questionnaire | |||
15 | Kaye et al [23] | Apr 2020 | Short communication study | 237 (108/129) | 237 | Unknown | 100% | Questionnaire | |||
16 | Ottaviano et al [24] | Apr 2020 | Case series | 6 | 6 | Unknown | 100% | Le Nez du Vinc | |||
17 | Heidari et al [25] | Apr 2020 | Case series | 23 (8/15) | 23 | Unknown | 100% | Questionnaire | |||
18 | Kim et al [26] | May 2020 | Cross-sectional study | 172 (66/106) | 68 | Unknown | 39.5% | Questionnaire | |||
19 | Boscolo-Rizzo et al [27] | May 2020 | Cross-sectional study | 54 | 34 | Unknown | 63% | Questionnaire | Comparison between probability of acute smell loss in COVID-19 and normal individual | ||
20 | Luers et al [28] | May 2020 | Retrospective study | 72 (41/31) | 53 | Unknown | 73.6% | Questionnaire | |||
21 | Vaira et al [29] | May 2020 | Cross-sectional study | 33 (11/22) | 17 | 13 | 4 | 51.5% | CCCRCb | ||
22 | Vaira et al [30] | Jun 2020 | Cross-sectional study | 72 (27/45) | 61 | 2 | 58 | 84.7% | CCCRCb | bSmell disorder identification by history 44 patients / by test 61 patients | |
23 | Boscolo-Rizzo et al [31] | Jul 2020 | Cross-sectional study | 187 (84/103) | 113 | Unknown | 60.4% | Questionnaire | |||
2549 M = 838 F = 1107 Unknown = 603 Gender diverse = 1 | 1453 | 376 | 270 | 2 | 57% |